url:https://finance.yahoo.com/m/2773a8db-bbdd-38f1-b9b1-57ce3bd5e17e/biogen-expects-sales-of.html
title:Biogen_Expects_Sales_of_Alzheimers_Drug_Leqembi_to_Start_Growing_Next_Year
Biogen expects sales of the Alzheimer's drug Leqembi to start ramping up in the first quarter of next year. The company’s partner Eisai reported $2 million in third quarter sales of Leqembi. “This was always going to be a gradual launch,” said Biogen CEO Chris Viehbacher on a conference call with analysts Wednesday.